1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Completed 1, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Advanced Cancer: new trials by email Literature Review of Advanced Cancer trials Research Report on Advanced Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors SXRN, Placebo - Advanced Cancer, Cachexia | Early Phase 1 | Recruiting | Jiangsu Nutai Biologics Co., Ltd | 28 | 2024-09-02 | 2026-05-15 |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer Recombinant oncolytic herpes simplex virus type Ⅰ (R130) - Cervical Cancer, Endometrial Cancer | Early Phase 1 | Unknown | Shanghai Yunying Medical Technology | 20 | 2023-02-06 | 2023-04-14 |
| Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden personalized DC vaccine - Advanced Cancer, Metastatic Cancer | Early Phase 1 | Withdrawn | Capital Medical University | 2018-09-11 | 2024-02-07 | |
| Temsirolimus In Phase 0 Temsirolimus - Advanced Cancer | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 15 | 2010-08-01 | 2014-06-23 |
Cachexia (1) · Endometrial Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Uterine Cervical Neoplasms (1)
Neoplasms (2) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Body Weight Changes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Thinness (1) · Urogenital Diseases (1)
temsirolimus (1)
Capital Medical University (1) · Jiangsu Nutai Biologics Co., Ltd (1) · M.D. Anderson Cancer Center (1) · Shanghai Yunying Medical Technology (1)
China (3) · United States (1)
Daniel Karp, MD (1)
K12CA088084 (1)